1.Interleukin-4 and osteoprotegerin suppress polyethylene wear debris-induced osteolysis in a murine air pouch model.
Yang WANG ; Rui ZHOU ; Ning-ning WU ; Yu-qin MOU ; Rui-dong LI ; Zhong-liang DENG
Journal of Southern Medical University 2011;31(10):1709-1713
OBJECTIVETo test the effect of recombinant interleukin-4 (IL-4) and recombinant osteoprotegerin (OPG) in suppressing bone resorption induced by polyethylene wear particles..
METHODSA cranial bone allograft was introduced into the air pouches induced on the back of BALB/c mice, followed by injection of 1 ml suspension of polyethylene particles into the pouches. The mouse models were then divided into 3 groups to receive injections of saline (control), IL-4 alone, or IL-4 and OPG into the pouches. The tissues were harvested 21 days after bone implantation for molecular and histological analyses.
RESULTSPolyethylene wear particles-stimulated inflammatory responses (increased cellular infiltration and IL-1 and TNF production) were markedly reduced by IL-4 treatment either alone or combined with OPG (P<0.05). Polyethylene particles significantly increased tartrate-resistant acid phosphatase (TRAP) staining and bone absorption of the implanted bone graft, and IL-4 treatment, either alone or combined with OPG, obviously reduced the osteolysis induced by polyethylene particles (P<0.05).
CONCLUSIONIL-4 offers protection against polyethylene wear debris-induced inflammation and bone resorption in this mouse model. IL-4 combined with OPG can be a feasible and effective therapeutic approach to the treatment and prevention of polyethylene wear debris-associated osteolysis and aseptic loosening of the prosthetic components.
Animals ; Bone Resorption ; chemically induced ; prevention & control ; Disease Models, Animal ; Female ; Interleukin-4 ; pharmacology ; Mice ; Mice, Inbred BALB C ; Orthopedic Fixation Devices ; adverse effects ; Osteolysis ; chemically induced ; prevention & control ; Osteoprotegerin ; pharmacology ; Polyethylene ; antagonists & inhibitors ; Recombinant Proteins ; pharmacology
2.Comparative Effects of Ibandronate and Paclitaxel on Immunocompetent Bone Metastasis Model.
Yoon Sok CHUNG ; Ho Chul KANG ; Taeyong LEE
Yonsei Medical Journal 2015;56(6):1643-1650
PURPOSE: Bone metastasis invariably increases morbidity and mortality. This study compares the effects of ibandronate and paclitaxel on bone structure and its mechanical properties and biochemical turnover in resorption markers using an immunocompetent Walker 256-Sprague-Dawley model, which was subjected to tumor-induced osteolysis. MATERIALS AND METHODS: Seventy rats were divided equally into 4 groups: 1) sham group (SHAM), 2) tumor group (CANC), 3) ibandronate treated group (IBAN), and 4) paclitaxel treated group (PAC). Morphological indices [bone volume fraction (BV/TV), trabecular number (Tb.N), trabecular thickness (Tb.Th), trabecular separation (Tb.Sp)] and mechanical properties (failure load, stiffness) were evaluated after thirty days of treatment period. Bone resorption rate was analysed using serum deoxypyridinoline (Dpd) concentrations. RESULTS: Morphological indices showed that ibandronate (anti-resorptive drug) had a better effect in treating tumor-induced architectural changes in bone than paclitaxel (chemotherapeutic drug). The deterioration in bone architecture was reflected in the biomechanical properties of bone as studied with decreased failure load (F(x)) and stiffness (S) of the bone on the 30th day postsurgery. Dpd concentrations were significantly lower in the IBAN group, indicating successful inhibition of bone resorption and destruction. CONCLUSION: Ibandronate was found to be as effective as higher doses of paclitaxel in maintaining stiffness of bone. Paclitaxel treatment did not appear to inhibit osteoclast resorption, which is contrary to earlier in-vitro literature. Emphasis should be placed on the use of immunocompetent models for examining drug efficacy since it adequately reflects bone metastasis in clinical scenarios.
Amino Acids
;
Animals
;
Biomechanical Phenomena/*drug effects/physiology
;
Bone Density/drug effects/physiology
;
Bone Neoplasms/*drug therapy
;
Bone Resorption/*chemically induced
;
Diphosphonates/*pharmacology
;
Immunocompetence
;
Male
;
*Neoplasm Metastasis
;
*Osteolysis
;
Paclitaxel/*pharmacology
;
Rats
;
Rats, Sprague-Dawley
3.Grape seed proanthocyanidin extract ameliorates monosodium iodoacetate-induced osteoarthritis.
Yun Ju WOO ; Young Bin JOO ; Young Ok JUNG ; Ji Hyeon JU ; Mi La CHO ; Hye Jwa OH ; Joo Youn JHUN ; Mi Kyung PARK ; Jin Sil PARK ; Chang Min KANG ; Mi Sook SUNG ; Sung Hwan PARK ; Ho Youn KIM ; Jun Ki MIN
Experimental & Molecular Medicine 2011;43(10):561-570
Osteoarthritis (OA) is an age-related joint disease that is characterized by degeneration of articular cartilage and chronic pain. Oxidative stress is considered one of the pathophysiological factors in the progression of OA. We investigated the effects of grape seed proanthocyanidin extract (GSPE), which is an antioxidant, on monosodium iodoacetate (MIA)-induced arthritis of the knee joint of rat, which is an animal model of human OA. GSPE (100 mg/kg or 300 mg/kg) or saline was given orally three times per week for 4 weeks after the MIA injection. Pain was measured using the paw withdrawal latency (PWL), the paw withdrawal threshold (PWT) and the hind limb weight bearing ability. Joint damage was assessed using histological and microscopic analysis and microcomputerized tomography. Matrix metalloproteinase-13 (MMP13) and nitrotyrosine were detected using immunohistochemistry. Administration of GSPE to the MIA-treated rats significantly increased the PWL and PWT and this resulted in recovery of hind paw weight distribution (P < 0.05). GSPE reduced the loss of chondrocytes and proteoglycan, the production of MMP13, nitrotyrosine and IL-1beta and the formation of osteophytes, and it reduced the number of subchondral bone fractures in the MIA-treated rats. These results indicate that GSPE is antinociceptive and it is protective against joint damage in the MIA-treated rat model of OA. GSPE could open up novel avenues for the treatment of OA.
Analgesics/*administration & dosage
;
Animals
;
Antioxidants/*administration & dosage
;
Bone Resorption
;
Disease Models, Animal
;
Gene Expression Regulation
;
Humans
;
Interleukin-1beta/genetics/metabolism
;
Iodoacetates/administration & dosage
;
Knee Joint/*drug effects/metabolism/pathology
;
Male
;
Matrix Metalloproteinase 13/genetics/metabolism
;
Osteoarthritis/chemically induced/*drug therapy/physiopathology
;
Pain
;
Plant Extracts/administration & dosage
;
Proanthocyanidins/*administration & dosage
;
Rats
;
Rats, Wistar
;
Seeds
;
Tomography, Emission-Computed
;
Tyrosine/analogs & derivatives/metabolism
;
Vitis/immunology
4.Grape seed proanthocyanidin extract ameliorates monosodium iodoacetate-induced osteoarthritis.
Yun Ju WOO ; Young Bin JOO ; Young Ok JUNG ; Ji Hyeon JU ; Mi La CHO ; Hye Jwa OH ; Joo Youn JHUN ; Mi Kyung PARK ; Jin Sil PARK ; Chang Min KANG ; Mi Sook SUNG ; Sung Hwan PARK ; Ho Youn KIM ; Jun Ki MIN
Experimental & Molecular Medicine 2011;43(10):561-570
Osteoarthritis (OA) is an age-related joint disease that is characterized by degeneration of articular cartilage and chronic pain. Oxidative stress is considered one of the pathophysiological factors in the progression of OA. We investigated the effects of grape seed proanthocyanidin extract (GSPE), which is an antioxidant, on monosodium iodoacetate (MIA)-induced arthritis of the knee joint of rat, which is an animal model of human OA. GSPE (100 mg/kg or 300 mg/kg) or saline was given orally three times per week for 4 weeks after the MIA injection. Pain was measured using the paw withdrawal latency (PWL), the paw withdrawal threshold (PWT) and the hind limb weight bearing ability. Joint damage was assessed using histological and microscopic analysis and microcomputerized tomography. Matrix metalloproteinase-13 (MMP13) and nitrotyrosine were detected using immunohistochemistry. Administration of GSPE to the MIA-treated rats significantly increased the PWL and PWT and this resulted in recovery of hind paw weight distribution (P < 0.05). GSPE reduced the loss of chondrocytes and proteoglycan, the production of MMP13, nitrotyrosine and IL-1beta and the formation of osteophytes, and it reduced the number of subchondral bone fractures in the MIA-treated rats. These results indicate that GSPE is antinociceptive and it is protective against joint damage in the MIA-treated rat model of OA. GSPE could open up novel avenues for the treatment of OA.
Analgesics/*administration & dosage
;
Animals
;
Antioxidants/*administration & dosage
;
Bone Resorption
;
Disease Models, Animal
;
Gene Expression Regulation
;
Humans
;
Interleukin-1beta/genetics/metabolism
;
Iodoacetates/administration & dosage
;
Knee Joint/*drug effects/metabolism/pathology
;
Male
;
Matrix Metalloproteinase 13/genetics/metabolism
;
Osteoarthritis/chemically induced/*drug therapy/physiopathology
;
Pain
;
Plant Extracts/administration & dosage
;
Proanthocyanidins/*administration & dosage
;
Rats
;
Rats, Wistar
;
Seeds
;
Tomography, Emission-Computed
;
Tyrosine/analogs & derivatives/metabolism
;
Vitis/immunology